cynomolgus monkeys were injected with ATL1103 over a 6 week period. IGF-I levels were suppressed by 35% relative to placebo, a level of effect, which if achieved in humans, would provide potential therapeutic benefit.
thats a 6 week mark for monkeys
i noticed at a 5 week mark after initial dose on charts show 3/8/ 2011 23 mill .008 - .010
just on my silly notes for later reference ..and for cross reference for own research ...
DYOR
